Midas Letter and C-Suite are excited to announce Midas Letter LIVE. Midas Letter highlights the stocks and stories to watch in the Canadian markets today. Host James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business News Network, CNBC, Bloomberg, Reuters, and CTV. James West and guests provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business. Midas Letter is excited to feature all investing content on C-suite.
Charting Man Dan Examines 2019 Prospects for Tier 2 Cannabis Companies
Charting Man Dan McDermitt, founding partner and analyst with the Chart Guys, explains the current relief bounce markets are experiencing and why Tier 2 cannabis names are surging. He highlights the correlation between oil prices, the S&P 500 and the cannabis space, noting that the recent relief bounce the sector is experiencing is following a surge in oil prices. McDermitt breaks down the cannabis industry into three tiers and suggests that large cap, Tier 1 names like Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) and Cronos Group Inc (TSE:CRON) (NASDAQ:CRON) (FRA:7CI) will be under more pressure to provide results this year. In contrast, mid cap, Tier 2 names like Organigram Holdings Inc (CVE:OGI) (OTCMKTS:OGRMF) (FRA:0OG) and HEXO Corp (TSE:HEXO) (OTCMKTS:HYYDF) (FRA:74H) should be more interesting for short-term traders as a lack of liquidity has helped share prices surge for Tier II names.